Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades For HIV Read more about Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades For HIV US Application 60/503,509Filed on 2003-09-15
Reagents And Approaches Relevant To The Diagnosis, Vaccinationa And Treatment Of SARS And Analysis Fo The Immune Response. Read more about Reagents And Approaches Relevant To The Diagnosis, Vaccinationa And Treatment Of SARS And Analysis Fo The Immune Response. US Application 60/503,508Filed on 2003-09-15
Streptococcus Lipoprotein Antigens Read more about Streptococcus Lipoprotein Antigens US Application 60/519,028Filed on 2003-11-10
Plasmodium Vivax Transporter Responsible For Chloroquine Resistance In Human Malaria Read more about Plasmodium Vivax Transporter Responsible For Chloroquine Resistance In Human Malaria US Application 60/153,197Filed on 1999-09-10
Accelerated Vaccination Read more about Accelerated Vaccination US Application 60/491,933Filed on 2003-08-01
Use Of Statin to Kill EBV-Transformed B Cells Read more about Use Of Statin to Kill EBV-Transformed B Cells US Application 60/515,013Filed on 2003-10-28
Enhancing The Structure Of Soluble HIV-1 Envelope Protein For Use As A Vaccine Component Read more about Enhancing The Structure Of Soluble HIV-1 Envelope Protein For Use As A Vaccine Component US Application 60/510,952Filed on 2003-10-10
GITR Ligand and Antibodies and Uses Thereof Read more about GITR Ligand and Antibodies and Uses Thereof US Application 60/472,844Filed on 2003-05-24
Recovery of Recombinant Human Metapneumovirus (HMPV) from cDNA and Use of Recombinant HMPV in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens Read more about Recovery of Recombinant Human Metapneumovirus (HMPV) from cDNA and Use of Recombinant HMPV in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens US Application 60/478,667Filed on 2003-06-13
The Generation and Use of Recombinant Forms of the Vaccinia Virus L1R and A33R Proteins as a Subunit Vaccine Read more about The Generation and Use of Recombinant Forms of the Vaccinia Virus L1R and A33R Proteins as a Subunit Vaccine US Application 60/451,337Filed on 2004-02-27